| 時間 | 主題 | 講者 | 座長 | 摘要 | 簡報 |
|---|---|---|---|---|---|
16:30 ~ 16:50 |
瀏覽海報時間 |
All |
王百孚, 虞凱傑 |
||
16:50 ~ 16:54 |
MP06-01: Is extraperitoneal extended pelvic lymph node dissection adequate during robotic assisted radical prostatectomy for intermediate and high risk localized prostate cancer? |
洪紹綸 |
王百孚, 虞凱傑 |
||
16:54 ~ 16:58 |
MP06-02: A single center experience of Abiraterone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel based chemotherapy |
蘇楷森 |
王百孚, 虞凱傑 |
||
16:58 ~ 17:02 |
MP06-03: Real world experience of androgen deprivation therapy associated bone fracture risk in newly diagnosed prostate cancer patients |
陳韋辰 |
王百孚, 虞凱傑 |
||
17:02 ~ 17:06 |
MP06-04: Hyperforin induces extrinsic/intrinsic apoptosis signaling and inhibits NF-кB for metastasis suppression in prostate cancer cells |
廖丞晞 |
王百孚, 虞凱傑 |
||
17:06 ~ 17:10 |
MP06-05: Retzius-sparing robot-assisted radical prostatectomy and extended pelvic lymph node dissection for very high-risk prostate cancer |
林威宇 |
王百孚, 虞凱傑 |
||
17:10 ~ 17:14 |
MP06-06: The analysis of concordance rates between cancer stage of MR/US fusion prostate biopsy and radical prostatectomy specimen |
康庭碩 |
王百孚, 虞凱傑 |
||
17:14 ~ 17:18 |
MP06-07: Oncological and functional outcomes in high risk and very high risk prostate cancer patients receiving robotic-assisted radical prostatectomy |
陳維心 |
王百孚, 虞凱傑 |
||
17:18 ~ 17:22 |
MP06-08: Treatment strategy and systemic review with PSMA PET/CT scan in progressive advanced prostate cancer |
謝博彥 |
王百孚, 虞凱傑 |
||
17:22 ~ 17:26 |
MP06-09: KCGMH experience and meta-analysis: 6-cycle complete rate of Radium-223 therapy in mCRPC patients with different treatment sequences |
江品葭 |
王百孚, 虞凱傑 |
||
17:26 ~ 17:30 |
MP06-10: Characteristics of mCRPC patients received Abiraterone acetate plus prednisolone and Enzalutamide before chemotherapy |
林晏頎 |
王百孚, 虞凱傑 |